S&P 500   2,995.99 (-0.36%)
DOW   26,788.10 (-0.15%)
QQQ   191.85 (-0.80%)
AAPL   239.96 (-0.23%)
FB   182.34 (-3.91%)
MSFT   136.37 (-1.49%)
GOOGL   1,241.20 (-0.25%)
AMZN   1,765.73 (-1.12%)
CGC   21.15 (+3.93%)
NVDA   195.61 (-0.20%)
MU   44.66 (-1.24%)
BABA   169.89 (-2.09%)
GE   9.06 (+3.07%)
TSLA   255.58 (+0.82%)
AMD   31.51 (-1.62%)
T   38.17 (-0.16%)
F   9.07 (+0.44%)
ACB   3.58 (-2.98%)
PRI   125.80 (+0.09%)
NFLX   266.69 (-4.09%)
BAC   31.20 (+0.58%)
GILD   65.86 (+1.00%)
DIS   132.40 (+1.64%)
S&P 500   2,995.99 (-0.36%)
DOW   26,788.10 (-0.15%)
QQQ   191.85 (-0.80%)
AAPL   239.96 (-0.23%)
FB   182.34 (-3.91%)
MSFT   136.37 (-1.49%)
GOOGL   1,241.20 (-0.25%)
AMZN   1,765.73 (-1.12%)
CGC   21.15 (+3.93%)
NVDA   195.61 (-0.20%)
MU   44.66 (-1.24%)
BABA   169.89 (-2.09%)
GE   9.06 (+3.07%)
TSLA   255.58 (+0.82%)
AMD   31.51 (-1.62%)
T   38.17 (-0.16%)
F   9.07 (+0.44%)
ACB   3.58 (-2.98%)
PRI   125.80 (+0.09%)
NFLX   266.69 (-4.09%)
BAC   31.20 (+0.58%)
GILD   65.86 (+1.00%)
DIS   132.40 (+1.64%)
Log in

GW Pharmaceuticals PLC- Price Target & Analyst Ratings (NASDAQ:GWPH)

$124.34
+2.86 (+2.35 %)
(As of 10/22/2019 04:00 PM ET)
Today's Range
$121.00
Now: $124.34
$125.41
50-Day Range
$108.42
MA: $126.10
$150.42
52-Week Range
$90.14
Now: $124.34
$196.00
Volume331,267 shs
Average Volume486,246 shs
Market Capitalization$3.84 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.23

Analyst Ratings

GW Pharmaceuticals PLC- (NASDAQ:GWPH) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
12 Wall Street analysts have issued ratings and price targets for GW Pharmaceuticals PLC- in the last 12 months. Their average twelve-month price target is $215.00, suggesting that the stock has a possible upside of 72.91%. The high price target for GWPH is $238.00 and the low price target for GWPH is $185.00. There are currently 12 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.002.912.91
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $215.00$215.00$206.78$179.00
Price Target Upside: 72.91% upside29.23% upside12.23% upside3.88% upside

GW Pharmaceuticals PLC- (NASDAQ:GWPH) Consensus Price Target History

GW Pharmaceuticals PLC- (NASDAQ:GWPH) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/21/2019Needham & Company LLCInitiated CoverageBuy$200.00Medium
9/27/2019OppenheimerLower Price TargetOutperform$239.00 ➝ $233.00Low
9/25/2019Bank of AmericaReiterated RatingBuy$218.00Medium
8/7/2019Morgan StanleyBoost Price TargetOverweight$238.00Low
7/26/2019CowenReiterated RatingBuy$200.00Medium
5/8/2019JPMorgan Chase & Co.UpgradeMarket Perform ➝ OutperformLow
5/7/2019GuggenheimReiterated RatingBuy ➝ Buy$186.00 ➝ $222.00Low
5/7/2019CIBCUpgradeMarket Perform ➝ OutperformHigh
5/7/2019Piper Jaffray CompaniesBoost Price TargetOverweight$185.00 ➝ $210.00High
5/7/2019Cantor FitzgeraldReiterated RatingPositive ➝ Overweight$196.00 ➝ $229.00High
1/7/2019AltaCorp CapitalReiterated RatingOutperformMedium
11/12/2018Leerink SwannInitiated CoverageOutperform$185.00Low
8/14/2018Stifel NicolausInitiated CoverageBuy$181.00Medium
12/14/2017Goldman Sachs GroupUpgradeNeutral ➝ Buy$174.00Medium
(Data available from 10/22/2017 forward)
This page was last updated on 10/22/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel